Editorial Contributor

Dr Joseph De Remigis, President, CEO of ELCAN
Dr Joseph De Remigis, President, CEO of ELCAN

The Raytheon Company assumed ownership of ELCAN in 1998. In order to maximise shareholder value and pursue new, high-value markets, Raytheon has mandated De Remigis to manage ELCAN as an autonomous, commercially focused organisation.

People Power

Dr Joseph De Remigis has taken optics company ELCAN through a period of dramatic change.



Home
New On This Site
Products & Services
Company A-Z
Case Studies
Special Features
White Papers
Jobs & Careers
Industry News
Gallery
Events
Newsletter
Advertise
Our Products
Client Area


RSS What is RSS
The essential component for medical manufacturing